Trial Outcomes & Findings for Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy (NCT NCT00654641)
NCT ID: NCT00654641
Last Updated: 2013-01-30
Results Overview
Superficial or deep space surgical site infection, or any type of wound disruption, including wound hematoma or seroma.
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
54 participants
Primary outcome timeframe
6 Weeks post-partum
Results posted on
2013-01-30
Participant Flow
Participant milestones
| Measure |
Negative Pressure Wound Closure
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
|
Standard Wound Closure
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
|
|---|---|---|
|
Overall Study
STARTED
|
28
|
26
|
|
Overall Study
COMPLETED
|
26
|
23
|
|
Overall Study
NOT COMPLETED
|
2
|
3
|
Reasons for withdrawal
| Measure |
Negative Pressure Wound Closure
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
|
Standard Wound Closure
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
2
|
3
|
Baseline Characteristics
Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy
Baseline characteristics by cohort
| Measure |
Negative Pressure Wound Closure
n=28 Participants
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
|
Standard Wound Closure
n=26 Participants
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
|
Total
n=54 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
28 Participants
n=99 Participants
|
26 Participants
n=107 Participants
|
54 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Sex: Female, Male
Female
|
28 Participants
n=99 Participants
|
26 Participants
n=107 Participants
|
54 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
28 participants
n=99 Participants
|
26 participants
n=107 Participants
|
54 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 6 Weeks post-partumSuperficial or deep space surgical site infection, or any type of wound disruption, including wound hematoma or seroma.
Outcome measures
| Measure |
Negative Pressure Wound Closure
n=28 Participants
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
|
Standard Wound Closure
n=26 Participants
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
|
|---|---|---|
|
Total Number of Patients Experiencing a Wound Complication
|
15 Participants
|
10 Participants
|
Adverse Events
Negative Pressure Wound Closure
Serious events: 0 serious events
Other events: 15 other events
Deaths: 0 deaths
Standard Wound Closure
Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Negative Pressure Wound Closure
n=28 participants at risk
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
|
Standard Wound Closure
n=26 participants at risk
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
|
|---|---|---|
|
Skin and subcutaneous tissue disorders
Wound complication
|
53.6%
15/28 • Number of events 15
|
38.5%
10/26 • Number of events 10
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place